Biguanide Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Biguanide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | ZITUVIMET XR | metformin hydrochloride; sitagliptin | TABLET, EXTENDED RELEASE;ORAL | 216778-003 | Jul 18, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | ZITUVIMET XR | metformin hydrochloride; sitagliptin | TABLET, EXTENDED RELEASE;ORAL | 216778-001 | Jul 18, 2024 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | ZITUVIMET XR | metformin hydrochloride; sitagliptin | TABLET, EXTENDED RELEASE;ORAL | 216778-002 | Jul 18, 2024 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | ZITUVIMET | metformin hydrochloride; sitagliptin | TABLET;ORAL | 216743-002 | Nov 3, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | ZITUVIMET | metformin hydrochloride; sitagliptin | TABLET;ORAL | 216743-001 | Nov 3, 2023 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Astrazeneca Ab | XIGDUO XR | dapagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205649-005 | Jul 28, 2017 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
